期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
Effect of visceral obesity on outcomes of fluorescence-guided lymphadenectomy during laparoscopic gastrectomy for gastric cancer:Post hoc analysis of a randomized phase 3 trial
1
作者 Yihui Tang Zening Huang +16 位作者 Xingqi Zhang Ping Li Jianwei Xie Jiabin Wang Qiyue Chen Longlong Cao Mi Lin Ruhong Tu Guangtan Lin Hualong Zheng Qing Zhong Juli Lin Zihao Yao Dong Wu Chaohui Zheng Jianxian Lin Changming Huang 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2024年第5期503-516,共14页
Objective:To explore the impact of visceral fat area(VFA)on the short-and long-term efficacy of indocyanine green(ICG)-guided D2 lymphadenectomy for gastric cancer(GC).Methods:A post hoc analysis was performed in pati... Objective:To explore the impact of visceral fat area(VFA)on the short-and long-term efficacy of indocyanine green(ICG)-guided D2 lymphadenectomy for gastric cancer(GC).Methods:A post hoc analysis was performed in patients who participated in a phase 3 randomized clinical trial of ICG-guided laparoscopic radical gastrectomy vs.conventional laparoscopic radical gastrectomy from November 2018 to July 2019.The VFA was calculated based on preoperative computed tomography images.Short-term efficacy included the quality of lymph node(LN)dissection and surgical outcomes,while long-term efficacy included overall survival(OS)and recurrence-free survival(RFS).Results:This study included 126 patients each in the ICG(high-VFA,n=43)and non-ICG groups(high-VFA,n=38).Compared with the non-ICG group,the ICG group had significantly more retrieved LNs(low-VFA:50.1 vs.43.9,P=0.001;high-VFA:49.6 vs.37.5,P<0.001)and a significantly lower LN noncompliance rate(low-VFA:32.5%vs.50.0%,P=0.020;high-VFA:32.6%vs.73.7%,P<0.001),regardless of the VFA.The ICG group had a shorter postoperative hospital stay and fewer intra-abdominal infections than the ICG group in the high-VFA patients(P=0.025 and P=0.020,respectively)but not in the low-VFA patients.Regardless of the VFA,the 3-year OS(RFS)was better in the ICG group than in the non-ICG group[low-VFA:83.1%(76.9%)vs.73.9%(67.0%);high-VFA:90.7%(90.7%)vs.73.7%(73.5%);P for interaction=0.474(0.547)].Conclusions:The short-and long-term efficacies of ICG tracing were not influenced by visceral obesity. 展开更多
关键词 Gastric cancer laparoscopic gastrectomy indocyanine green visceral obesity lymph node dissection survival
下载PDF
Relationship between visceral obesity and prognosis in patients with stage IVB cervical cancer receiving radiotherapy and chemotherapy
2
作者 Chao Ji Silin Liu +5 位作者 Che Wang Jie Chen Jin Wang Xinyue Zhang Jinlu Ma Mengjiao Cai 《Cancer Pathogenesis and Therapy》 2024年第3期180-186,共7页
Background:Concurrent chemoradiotherapy is the preferred treatment for stage IVB cervical cancer;however,some patients experience a poor prognosis.The prognostic significance of body composition indicators,including v... Background:Concurrent chemoradiotherapy is the preferred treatment for stage IVB cervical cancer;however,some patients experience a poor prognosis.The prognostic significance of body composition indicators,including visceral obesity,has been extensively investigated in patients with cancer.This study aimed to assess the impact of body composition indicators,specifically pretreatment fat content,on the survival outcomes of patients with stage IVB cervical cancer.Methods:We retrospectively analyzed clinical information from patients diagnosed with stage IVB cervical cancer between 2010 and 2018.We measured visceral obesity(visceral-to-subcutaneous adipose tissue area ratio[VSR])and skeletal muscle index(SMI)on pretreatment computed tomography(CT)images.We evaluated the impact of these body composition parameters on the prognosis of patients with cervical cancer.Results:Overall,116 patients were included,81 of whom had complete clinical and imaging information.Based on the cut-off values from X-tile analysis,we categorized patients into high and low VSR and SMI groups.The overall survival(OS)rate of patients with a high VSR was significantly higher than that of patients with a low VSR(P=0.022).Multivariate Cox regression analysis showed that a low VSR was an independent risk factor for the prognosis of patients with stage IVB cervical cancer.Conclusion:Visceral obesity before radiotherapy and chemotherapy has a protective effect on the prognosis of patients with stage IVB cervical cancer,while low muscle index and VSR are associated with poor prognosis. 展开更多
关键词 Cervical cancer CHEMORADIOTHERAPY visceral obesity PROGNOSIS
原文传递
Estrogen restores disordered lipid metabolism in visceral fat of prediabetic mice
3
作者 Su-Huan Liu Zhao-Shui Shangguan +3 位作者 Paiziliya Maitiaximu Zhi-Peng Li Xin-Xin Chen Can-Dong Li 《World Journal of Diabetes》 SCIE 2024年第5期988-1000,共13页
BACKGROUND Visceral obesity is increasingly prevalent among adolescents and young adults and is commonly recognized as a risk factor for type 2 diabetes.Estrogen[17β-estradiol(E2)]is known to offer protection against... BACKGROUND Visceral obesity is increasingly prevalent among adolescents and young adults and is commonly recognized as a risk factor for type 2 diabetes.Estrogen[17β-estradiol(E2)]is known to offer protection against obesity via diverse me-chanisms,while its specific effects on visceral adipose tissue(VAT)remain to be fully elucidated.AIM To investigate the impact of E2 on the gene expression profile within VAT of a mouse model of prediabetes.METHODS Metabolic parameters were collected,encompassing body weight,weights of visceral and subcutaneous adipose tissues(VAT and SAT),random blood glucose levels,glucose tolerance,insulin tolerance,and overall body composition.The gene expression profiles of VAT were quantified utilizing the Whole Mouse Genome Oligo Microarray and subsequently analyzed through Agilent Feature Extraction software.Functional and pathway analyses were conducted employing Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses,respectively.RESULTS Feeding a high-fat diet(HFD)moderately increased the weights of both VAT and SAT,but this increase was mitigated by the protective effect of endogenous E2.Conversely,ovariectomy(OVX)led to a significant increase in VAT weight and the VAT/SAT weight ratio,and this increase was also reversed with E2 treatment.Notably,OVX diminished the expression of genes involved in lipid metabolism compared to HFD feeding alone,signaling a widespread reduction in lipid metabolic activity,which was completely counteracted by E2 adminis-tration.This study provides a comprehensive insight into E2's local and direct protective effects against visceral adiposity in VAT at the gene level.CONCLUSION In conclusion,the present study demonstrated that the HFD-induced over-nutritional challenge disrupted the gene expression profile of visceral fat,leading to a universally decreased lipid metabolic status in E2 deficient mice.E2 treatment effectively reversed this condition,shedding light on the mechanistic role and therapeutic potential of E2 in combating visceral obesity. 展开更多
关键词 ESTROGEN obesity visceral adiposity Energy metabolism Type 2 diabetes
下载PDF
Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping 被引量:1
4
作者 Shahid Habib 《World Journal of Gastrointestinal Pathophysiology》 2024年第2期1-14,共14页
Metabolic dysfunction-associated steatotic liver disease(MASLD)is a widespread global disease with significant health burden.Unhealthy lifestyle,obesity,diabetes mellitus(DM),insulin resistance,and genetics have been ... Metabolic dysfunction-associated steatotic liver disease(MASLD)is a widespread global disease with significant health burden.Unhealthy lifestyle,obesity,diabetes mellitus(DM),insulin resistance,and genetics have been implicated in the pathogenesis of MASLD.A significant degree of heterogeneity exists among each of above-mentioned risk factors.Heterogeneity of these risk factors translates into the heterogeneity of MASLD.On the other hand,MASLD can itself lead to insulin resistance and DM.Such heterogeneity makes it difficult to assess the natural course of an individual with MASLD in clinical practice.At present MASLD is considered as one disease despite the variability of etiopathogenic processes,and we lack the consensus definitions of unique subtypes of MASLD.In this review,pathogenic processes of MASLD are discussed and a need of subtyping is recommended. 展开更多
关键词 Metabolic dysfunctions-associated steatotic liver disease visceral obesity GENETICS Diabetes Insulin resistance
下载PDF
Predictors for difficult cecal insertion in colonoscopy: The impact of obesity indices 被引量:7
5
作者 Soo Yun Moon Byung Chang Kim +6 位作者 Dae Kyung Sohn Kyung Su Han Bun Kim Chang Won Hong Bum Joon Park Kum Hei Ryu Ji Hyung Nam 《World Journal of Gastroenterology》 SCIE CAS 2017年第13期2346-2354,共9页
AIM To identify the factors influencing cecal insertion time(CIT) and to evaluate the effect of obesity indices on CIT. METHODS We retrospectively reviewed the data for participants who received both colonoscopy and a... AIM To identify the factors influencing cecal insertion time(CIT) and to evaluate the effect of obesity indices on CIT. METHODS We retrospectively reviewed the data for participants who received both colonoscopy and abdominal computed tomography(CT) from February 2008 to May 2008 as part of a comprehensive health screening program. Age, gender, obesity indices [body mass index(BMI), waist-to-hip circumference ratio(WHR), waist circumference(WC), visceral adipose tissue(VAT)volume and subcutaneous adipose tissue(SAT) volume on abdominal CT], history of prior abdominal surgery, constipation, experience of the colonoscopist, quality of bowel preparation, diverticulosis and time required to reach the cecum were analyzed. CIT was categorized as longer than 10 min(prolonged CIT) and shorter than or equal to 10 min, and then the factors that required a CIT longer than 10 min were examined.RESULTS A total of 1678 participants were enrolled. The mean age was 50.42 ± 9.931 years and 60.3% were men. The mean BMI, WHR, WC, VAT volume and SAT volume were 23.92 ± 2.964 kg/m2, 0.90 ± 0.076, 86.95 ± 8.030 cm, 905.29 ± 475.220 cm3 and 1707.72 ± 576.550 cm3, respectively. The number of patients who underwent abdominal surgery was 268(16.0%). Colonoscopy was performed by an attending physician alone in 61.9% of cases and with the involvement of a fellow in 38.1% of cases. The median CIT was 7 min(range 2-56 min, IQR 5-10 min), and mean CIT was 8.58 ± 5.291 min. Being female, BMI, VAT volume and involvement of fellow were significantly associated with a prolonged CIT in univariable analysis. In multivariable analysis, being female(OR = 1.29, P = 0.047), lower BMI(< 23 kg/m2)(OR = 1.62, P = 0.004) or higher BMI(≥ 25 kg/m2)(OR = 1.80, P < 0.001), low VAT volume(< 500 cm3)(OR = 1.50, P = 0.013) and fellow involvement(OR = 1.73, P < 0.001) were significant predictors of prolonged CIT. In subgroup analyses for gender, lower BMI or higher BMI and fellow involvement were predictors for prolonged CIT in both genders. However, low VAT volume was associated with prolonged CIT in only women(OR = 1.54, P = 0.034).CONCLUSION Being female, having a lower or higher BMI than the normal range, a low VAT volume, and fellow involvement were predictors of a longer CIT. 展开更多
关键词 visceral obesity Difficult colonoscopy Cecal insertion time Body mass index Female
下载PDF
Interaction between hepatitis C virus and metabolic factors 被引量:5
6
作者 Yasunori Kawaguchi Toshihiko Mizuta 《World Journal of Gastroenterology》 SCIE CAS 2014年第11期2888-2901,共14页
Hepatitis C virus (HCV) infection disrupts the normal metabolism processes, but is also influenced by several of the host&#x02019;s metabolic factors. An obvious and significantly detrimental pathophysiological fe... Hepatitis C virus (HCV) infection disrupts the normal metabolism processes, but is also influenced by several of the host&#x02019;s metabolic factors. An obvious and significantly detrimental pathophysiological feature of HCV infection is insulin resistance in hepatic and peripheral tissues. Substantial research efforts have been put forth recently to elucidate the molecular mechanism of HCV-induced insulin resistance, and several cytokines, such as tumor necrosis factor-&#x003b1;, have been identified as important contributors to the development of insulin resistance in the distant peripheral tissues of HCV-infected patients and animal models. The demonstrated etiologies of HCV-induced whole-body insulin resistance include oxidative stress, lipid metabolism abnormalities, hepatic steatosis and iron overload. In addition, myriad effects of this condition have been characterized, including glucose intolerance, resistance to antiviral therapy, progression of hepatic fibrosis, development of hepatocellular carcinoma, and general decrease in quality of life. Metabolic-related conditions and disorders, such as visceral obesity and diabetes mellitus, have been shown to synergistically enhance HCV-induced metabolic disturbance, and are associated with worse prognosis. Yet, the molecular interactions between HCV-induced metabolic disturbance and host-associated metabolic factors remain largely unknown. The diet and lifestyle recommendations for chronic hepatitis C are basically the same as those for obesity, diabetes, and metabolic syndrome. Specifically, patients are suggested to restrict their dietary iron intake, abstain from alcohol and tobacco, and increase their intake of green tea and coffee (to attain the beneficial effects of caffeine and polyphenols). While successful clinical management of HCV-infected patients with metabolic disorders has also been achieved with some anti-diabetic (i.e., metformin) and anti-lipid (i.e., statins) medications, it is recommended that sulfonylurea and insulin be avoided. 展开更多
关键词 Hepatitis C virus Insulin resistance DIABETES Lipid metabolism abnormality Hepatic steatosis Iron overload Oxidative stress visceral obesity
下载PDF
Fatty liver is an independent risk factor for gallbladder polyps 被引量:4
7
作者 Dong-Won Ahn Ji Bong Jeong +8 位作者 Jinwoo Kang Su Hwan Kim Ji Won Kim Byeong Gwan Kim Kook Lae Lee Sohee Oh Soon Ho Yoon Sang Joon Park Doo Hee Lee 《World Journal of Gastroenterology》 SCIE CAS 2020年第44期6979-6992,共14页
BACKGROUND Gallbladder polyps(GBPs)are known to be associated with obesity and metabolic diseases.However,to date,the relationship between GBPs and abnormal body fat distribution,such as fatty liver,visceral obesity,o... BACKGROUND Gallbladder polyps(GBPs)are known to be associated with obesity and metabolic diseases.However,to date,the relationship between GBPs and abnormal body fat distribution,such as fatty liver,visceral obesity,or sarcopenia,has not yet been established.AIM To evaluate whether GBPs are associated with fatty liver,visceral obesity,or sarcopenia.METHODS We retrospectively reviewed the medical records of subjects who underwent various laboratory tests,body composition measurement with a non-invasive body composition analyzer,and abdominal ultrasonography during health checkups.A total of 1405 subjects with GBPs were compared with 2810 age-and sex-matched controls.RESULTS The mean age of the subjects was 46.8±11.7 years,and 63.8%were male.According to multiple logistic regression analysis,the presence of fatty liver[odds ratio(OR)1.413;95%confidence interval(CI)1.218-1.638;P<0.001]was an independent risk factor for GBP,together with low levels of alanine aminotransferase(OR 0.993;95%CI 0.989-0.996;P<0.001).Additionally,fatty liver showed both independent(OR 1.629;95%CI,1.335-1.988;P<0.001)and dosedependent(moderate to severe fatty liver;OR 2.137;95%CI,1.662-2.749;P<0.001)relationship with large GBPs(≥5 mm).The presence of sarcopenia and high visceral fat area were not significantly associated with GBPs.CONCLUSION Fatty liver was found to be closely associated with GBPs irrespective of sarcopenia and visceral obesity. 展开更多
关键词 Gallbladder polyp Fatty liver SARCOPENIA visceral obesity Risk factors Body fat distribution
下载PDF
Correlation between Waist Circumference and Carotid Intima-Media Thickness in Women from Shanghai, China 被引量:4
8
作者 SHEN Yun ZHANG Lei +7 位作者 ZONG Wen Hong WANG Zheng ZHANG Yin YANG Man Jing MA Xiao Jing ZHU Jia An BAO YuQian JIA Wei Ping 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2013年第7期531-538,共8页
Objective To evaluate whether waist circumference (WC) 〉85 cm is related to asymptomatic preclinical atherosclerosis in women from Shanghai, China. Methods A total of 2365 females aged 〉20 years recruited from 4 c... Objective To evaluate whether waist circumference (WC) 〉85 cm is related to asymptomatic preclinical atherosclerosis in women from Shanghai, China. Methods A total of 2365 females aged 〉20 years recruited from 4 communities underwent physical examination and carotid artery scanning. Their carotid intima-media thickness (C-iMT) was measured. Results The C-IMT was significantly higher in overweight or obese women with their BMI 〉25.0 kg/m2 {P〈O.01) and in those with their WC _〉85 cm than in those with their WC 〈85 cm (P〈O.01). Spearman and partial correlation analysis showed that the C-IMT was significantly correlated with WC which was independent of menopausal status. The C-IMT significantly increased with the increasing WC and reached to a platform in about 85 cm. An increment tendency was found in the subgroup with its WC 〈 85 cm (P〈O.01) while no significant tendency was found in the subgroup with its WC_〉85 cm (P=0.07). Multiple stepwise regression analysis showed that the WC was an independent risk factor for C-IMT. In logistic regression model, the odd ratio of WC _〉80 cm, _〉80 cm and 〈85 cm and 〉85 cm for evaluating the risk of C-IMT elevation was 2.632, 2.501, and 1.878, respectively. Conclusion WC is significantly correlated with C-IMT in women from Shanghai, China, and WC_〉85 cm may be used in identifying the risk of subclinical carotid atherosclerosis. 展开更多
关键词 visceral obesity Waist circumference Carotid intima-media thickness
下载PDF
Lipid Accumulation Product: Reliable Marker for Cardiovascular Risk Detection?
9
作者 Lidiane Aparecida Vila Pires Ricardo José Tofano +7 位作者 Sandra Maria Barbalho Claudia Rucco Penteado Detregiachi Marcelo Dib Bechara Viviane Alessandra Capelluppi Tofano Jesselina Francisco dos Santos Haber Eduardo Federighi Baisi Chagas Ana Maria Gonçalvez Milla Karina Quesada 《Open Journal of Epidemiology》 2021年第3期267-277,共11页
<span style="font-family:Verdana;">The Lipid Accumulation Product (LAP) is a clinical marker of visceral obesity and has been proposed as a simple, inexpensive, and accurate tool to estimate cardiovasc... <span style="font-family:Verdana;">The Lipid Accumulation Product (LAP) is a clinical marker of visceral obesity and has been proposed as a simple, inexpensive, and accurate tool to estimate cardiovascular risk and mortality. The aim of this study was to verify the association of LAP with anthropometric, biochemical, visceral adiposity index and IR in adults and the elderly. This single cross-section center clinical study, with experimental, analytical, primary, and observational design, included 210 participants. Anthropometric (Body Mass Index (BMI), Waist Circumference (WC), and Neck Circumference (NC)), LAP, Visceral Adipose Index (VAI), and biochemical parameters (fasting glycemia, insulinemia (to calculate the Homa-IR index), total cholesterol, LDL-c, HDL-c, and triglycerides) were evaluated. The results showed that by separating the sample into three groups (adequate BMI and WC, adequate BMI and elevated WC, and elevated BMI and WC), the group with high BMI and WC showed a high value of LAP and VAI compared to the other groups, with a significant difference. Still, the data show a positive and significant correlation when relating the LAP with VAI, HOMA-IR, BMI, WC, NC, total cholesterol, triglycerides, and Diastolic Blood Pressure. It also showed an inversely proportional relationship when associating LAP with HDL-c (p < 0.0001). Thus, we show that LAP is closely related to visceral adiposity, IR, altered lipid parameters, and blood pressure, especially diastolic in the patients included in our study. For these reasons, we suggest that LAP is a reliable indicator of promising visceral adiposity for early detection of cardiovascular risk in the adult and senior population.</span> 展开更多
关键词 Lipid Accumulation Product obesity. visceral obesity Metabolic Syndrome Cardiovascular Risk
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部